BioMarin Pharmaceutical stock forecast
BioMarin Pharmaceutical (BM8) Stock Forecast & Price Target
BM8 Analyst Ratings
BM8 Stock 12 Month Forecast
Average Price Target
€80.50▲(58.21% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Mitchell Kapoor | H.C. Wainwright | €54.44 | hold | 6.99%Upside | Reiterated | 11/16/26 | ||
| Sean Laaman | Morgan Stanley | €107.96→€93.45 | buy | 83.66%Upside | Assigned | 11/13/26 | ||
| Cory Kasimov | Evercore ISI | €108.87 | buy | 113.97%Upside | Reiterated | 11/13/26 | ||
| Eliana Merle | Barclays | €103.43 | buy | 103.28%Upside | Reiterated | 11/04/26 | ||
| Jessica Fye | J.P. Morgan | €78.93→€78.02 | buy | 53.35%Upside | Reiterated | 11/04/26 | ||
| Mohit Bansal | Wells Fargo | €72.58 | buy | 42.65%Upside | Assigned | 11/03/26 | ||
| Paul Matteis | Stifel Nicolaus | €63.51→€59.88 | hold | 17.69%Upside | Reiterated | 11/03/26 | ||
| Yun Zhong | Wedbush | €85.28→€80.75 | buy | 58.70%Upside | Assigned | 11/03/26 | ||
| Joon Lee | UBS | €79.84 | buy | 56.91%Upside | Reiterated | 11/03/26 | ||
| Leland Gershell | Oppenheimer | €88.00→€85.28 | buy | 67.61%Upside | Reiterated | 11/03/26 | ||
| Phil Nadeau | TD Cowen | €108.87 | buy | 113.97%Upside | Reiterated | 11/03/26 | ||
| Eric Joseph | Citi | €68.95 | buy | 35.52%Upside | Reiterated | 11/02/26 | ||
| Luca Issi | RBC Capital | €56.25→€54.44 | hold | 6.99%Upside | Reiterated | 11/02/26 | ||
| Olivia Brayer | Cantor Fitzgerald | €78.02 | buy | 53.35%Upside | Reiterated | 11/02/26 | ||
| Jason Gerberry | Bank of America Securities | €78.02→€75.30 | buy | 48.00%Upside | Reiterated | 11/02/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Mitchell KapoorH.C. Wainwright | HoldReiterated€54.44 | 11/16/26 | 6.99%Upside | ||
| Sean LaamanMorgan Stanley | BuyAssigned€107.96→€93.45 | 11/13/26 | 83.66%Upside | ||
| Cory KasimovEvercore ISI | BuyReiterated€108.87 | 11/13/26 | 113.97%Upside | ||
| Eliana MerleBarclays | BuyReiterated€103.43 | 11/04/26 | 103.28%Upside | ||
| Jessica FyeJ.P. Morgan | BuyReiterated€78.93→€78.02 | 11/04/26 | 53.35%Upside | ||
| Mohit BansalWells Fargo | BuyAssigned€72.58 | 11/03/26 | 42.65%Upside | ||
| Paul MatteisStifel Nicolaus | HoldReiterated€63.51→€59.88 | 11/03/26 | 17.69%Upside | ||
| Yun ZhongWedbush | BuyAssigned€85.28→€80.75 | 11/03/26 | 58.70%Upside | ||
| Joon LeeUBS | BuyReiterated€79.84 | 11/03/26 | 56.91%Upside | ||
| Leland GershellOppenheimer | BuyReiterated€88.00→€85.28 | 11/03/26 | 67.61%Upside | ||
| Phil NadeauTD Cowen | BuyReiterated€108.87 | 11/03/26 | 113.97%Upside | ||
| Eric JosephCiti | BuyReiterated€68.95 | 11/02/26 | 35.52%Upside | ||
| Luca IssiRBC Capital | HoldReiterated€56.25→€54.44 | 11/02/26 | 6.99%Upside | ||
| Olivia BrayerCantor Fitzgerald | BuyReiterated€78.02 | 11/02/26 | 53.35%Upside | ||
| Jason GerberryBank of America Securities | BuyReiterated€78.02→€75.30 | 11/02/26 | 48.00%Upside |
Best Analysts Covering BioMarin Pharmaceutical
Copying Christopher Raymond's trades and holding each position for 3 Months would result in 41.67% of your transactions generating a profit, with an average return of -0.44% per trade.
Copying Cory Kasimov's trades and holding each position for 1 Year would result in 44.19% of your transactions generating a profit, with an average return of -4.32% per trade.
Copying Phil Nadeau's trades and holding each position for 2 Years would result in 42.86% of your transactions generating a profit, with an average return of -5.24% per trade.
BM8 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 25 | 16 | 17 | 26 | 23 |
| Buy | 7 | 10 | 17 | 17 | 12 |
| Hold | 13 | 14 | 15 | 13 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 45 | 40 | 49 | 56 | 43 |
In the current month, BM8 has received 35 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. BM8 average Analyst price target in the past 3 months is 80.50.
BM8 Financial Forecast
BM8 Earnings Forecast
Next quarter’s earnings estimate for BM8 is EUR 0.74 with a range of EUR 0.60 to EUR 0.87. The previous quarter’s EPS was EUR 0.21. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
BM8 Sales Forecast
Next quarter’s sales forecast for BM8 is EUR 984.59M with a range of EUR 956.30M to EUR 1.01B. The previous quarter’s sales results were EUR 926.12M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

